Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Friday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Trading Up 3.5 %

Shares of Milestone Scientific stock opened at $0.80 on Friday. Milestone Scientific has a 1-year low of $0.52 and a 1-year high of $1.10. The firm’s 50-day moving average price is $0.81 and its two-hundred day moving average price is $0.86. The stock has a market capitalization of $62.09 million, a price-to-earnings ratio of -11.39 and a beta of 1.10.

Insider Buying and Selling at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 24.75% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Milestone Scientific

Several hedge funds and other institutional investors have recently modified their holdings of MLSS. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific in the 3rd quarter worth about $48,000. World Investment Advisors LLC purchased a new position in Milestone Scientific during the 3rd quarter worth $91,000. Finally, Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the period. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.